News

BioVersys in the News

14.11.2020
Innovation im Kampf gegen eine schleichende Pandemie
31.12.2018
BioVersys is featured in a Forbes France special
27.11.2018
Fresh funds to fuel the fight against drug-resistant bacteria
03.09.2018
An interesting and informative report on bacteria and antibiotic resistance
19.06.2018
Increase In Antibacterial R&D Prompts EMA Proposal For Improved Guidance
12.05.2017
Beobachter 10/2017: Die Tuberkulose überlistet. Ein Interview mit Marc Gitzinger
17.03.2017
AMR Industry report and case study BioVersys
07.03.2017
Bioversys AG and Aptuit Announce Collaboration to Identify Novel Approaches to Treat Serious Infections from Gram-Negative Pathogens
03.10.2016
Marc Gitzinger wins innovation prize for BioVersys AG